Related Experiment Videos
A di(bisphosphonic acid) for protein coupling and targeting to bone
Geeti Bansal1, Sébastien A Gittens, Hasan Uludağ
1Department of Chemical and Materials Engineering, Faculty of Engineering, University of Alberta, Edmonton, Alberta, Canada T6G 2G6.
Journal of Pharmaceutical Sciences
|September 16, 2004
Summary
Researchers developed a novel bisphosphonate (BP) capable of targeting bone. This new BP, when attached to proteins, enhances their bone-seeking ability for potential bone disease treatments.
Area of Science:
- Biomaterials Science
- Drug Delivery
- Bone Biology
Background:
- Proteins for treating bone diseases require high bone affinity for effective systemic delivery.
- Bisphosphonates (BPs) are known for their strong affinity to bone minerals.
Purpose of the Study:
- To synthesize a novel bisphosphonate (BP) with enhanced bone-targeting capabilities.
- To conjugate the novel BP to model proteins and evaluate their bone-seeking properties.
Main Methods:
- Synthesis of a novel bisphosphonate (6) with two BP moieties.
- Carbodiimide chemistry was used to conjugate BP 6 to bovine serum albumin and immunoglobulin G.
- In vitro mineral binding assays and in vivo bone targeting studies in rats were performed.
Main Results:
- The novel BP (6) was successfully synthesized and conjugated to proteins with controlled efficiency.
- Protein-BP conjugates demonstrated in vitro bone mineral affinity proportional to the BP load.
- In vivo studies confirmed that the BP-conjugated proteins were preferentially deposited in rat bones.
Conclusions:
- The novel bisphosphonate (6) effectively enhances protein bone targeting.
- This BP can serve as a carrier for bone delivery, minimizing protein modification.
- This approach offers a promising strategy for developing bone-targeted protein therapeutics.